Literature DB >> 29352061

What to do about fibrin rich 'tough clots'? Comparing the Solitaire stent retriever with a novel geometric clot extractor in an in vitro stroke model.

Vernard S Fennell1, Swetadri Vasan Setlur Nagesh2, Karen M Meess3,4,5, Liza Gutierrez6, Rhys H James3, Michael E Springer3, Adnan H Siddiqui3,7.   

Abstract

BACKGROUND: Despite advances in revascularization tools for large vessel occlusion presenting as acute ischemic stroke, a significant subset of clots remain recalcitrant to current strategies. We assessed the effectiveness of a novel thrombectomy device that was specifically designed to retrieve resistant fibrin rich clots, the geometric clot extractor (GCE; Neuravi, Galway, Ireland), in an in vitro cerebrovascular occlusion stroke model.
METHODS: After introducing fibrin rich clot analogues into the middle cerebral artery of the model, we compared the rates of recanalization between GCE and Solitaire flow restoration stent retriever (SR; Medtronic, Minneapolis, Minnesota, USA; control group) cases. A maximum of three passes of each device was allowed. If the SR failed to recanalize the vessel after three passes, one pass of the GCE was allowed (rescue cases).
RESULTS: In a total of 26 thrombectomy cases (13 GCE, 13 SR), successful recanalization (Thrombolysis in Cerebral Infarction score of 2b or 3) was achieved 100% of the time in the GCE cases with an average of 2.13 passes per case. This rate was significantly higher compared with the Solitaire recanalization rate (7.7%, P<0.0001) with an average of three passes per case. After SR failure (in 92% of cases), successful one pass GCE rescue recanalization was achieved 66% of the time (P<0.005).
CONCLUSION: Application of the GCE in this experimental stroke model to retrieve typically recalcitrant fibrin rich clots resulted in higher successful recanalization rates than the SR. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  flow diverter; stroke; technique; technology; thrombectomy

Mesh:

Substances:

Year:  2018        PMID: 29352061     DOI: 10.1136/neurintsurg-2017-013507

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  22 in total

1.  MRI Quantitative T2* Mapping to Predict Dominant Composition of In Vitro Thrombus.

Authors:  R Bourcier; R Pautre; M Mirza; C Castets; J Darcourt; J Labreuche; L Detraz; H Desal; J-M Serfaty; C Toquet
Journal:  AJNR Am J Neuroradiol       Date:  2019-01       Impact factor: 3.825

2.  Thrombus perviousness is not associated with first-pass revascularization using stent retrievers.

Authors:  Jun-Soo Byun; Patrick Nicholson; Christopher A Hilditch; Anderson Chun On Tsang; Vitor Mendes Pereira; Timo Krings; Yibin Fang; Waleed Brinjikji
Journal:  Interv Neuroradiol       Date:  2019-02-04       Impact factor: 1.610

3.  Large animals in neurointerventional research: A systematic review on models, techniques and their application in endovascular procedures for stroke, aneurysms and vascular malformations.

Authors:  Andrea M Herrmann; Stephan Meckel; Matthew J Gounis; Leona Kringe; Edith Motschall; Christoph Mülling; Johannes Boltze
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-07       Impact factor: 6.200

Review 4.  Imaging Clot Characteristics in Stroke and its Possible Implication on Treatment.

Authors:  Ana Siri Luthman; Laurie Bouchez; Daniele Botta; Maria Isabel Vargas; Paolo Machi; Karl-Olof Lövblad
Journal:  Clin Neuroradiol       Date:  2019-10-10       Impact factor: 3.649

5.  Longer 6-mm Diameter Stent Retrievers Are Effective for Achieving Higher First Pass Success with Fibrin-Rich Clots.

Authors:  Gaurav Girdhar; Evan Epstein; Kevin Nguyen; Chelsea Gregg; Tejashri Kumar; John Wainwright; Amon Y Liu; Italo Linfante
Journal:  Interv Neurol       Date:  2019-06-18

Review 6.  Clot Pathophysiology: Why Is It Clinically Important?

Authors:  Patrick A Brouwer; Waleed Brinjikji; Simon F De Meyer
Journal:  Neuroimaging Clin N Am       Date:  2018-09-15       Impact factor: 2.264

7.  Institution of Code Neurointervention and Its Impact on Reaction and Treatment Times.

Authors:  Spozhmy Panezai; Sanket Meghpara; Ashish Kulhari; Jaskiran Brar; Laura Suhan; Amrinder Singh; Siddhart Mehta; Haralabous Zacharatos; Sara Strauss; Jawad Kirmani
Journal:  J Vasc Interv Neurol       Date:  2020-01

Review 8.  Studying Stroke Thrombus Composition After Thrombectomy: What Can We Learn?

Authors:  Senna Staessens; Olivier François; Waleed Brinjikji; Karen M Doyle; Peter Vanacker; Tommy Andersson; Simon F De Meyer
Journal:  Stroke       Date:  2021-09-14       Impact factor: 7.914

9.  A new aspiration device equipped with a hydro-separator for acute ischemic stroke due to challenging soft and stiff clots.

Authors:  Naoki Kaneko; Mahsa Ghovvati; Yutaro Komuro; Lea Guo; Kasra Khatibi; Lucido L Ponce Mejia; Hamidreza Saber; Nasim Annabi; Satoshi Tateshima
Journal:  Interv Neuroradiol       Date:  2021-05-05       Impact factor: 1.610

10.  Association of Time From Stroke Onset to Groin Puncture With Quality of Reperfusion After Mechanical Thrombectomy: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials.

Authors:  Romain Bourcier; Mayank Goyal; David S Liebeskind; Keith W Muir; Hubert Desal; Adnan H Siddiqui; Diederik W J Dippel; Charles B Majoie; Wim H van Zwam; Tudor G Jovin; Elad I Levy; Peter J Mitchell; Olvert A Berkhemer; Stephen M Davis; Imad Derraz; Geoffrey A Donnan; Andrew M Demchuk; Robert J van Oostenbrugge; Michael Kelly; Yvo B Roos; Reza Jahan; Aad van der Lugt; Marieke Sprengers; Stephane Velasco; Geert J Lycklama À Nijeholt; Wagih Ben Hassen; Paul Burns; Scott Brown; Emmanuel Chabert; Timo Krings; Hana Choe; Christian Weimar; Bruce C V Campbell; Gary A Ford; Marc Ribo; Phil White; Geoffrey C Cloud; Luis San Roman; Antoni Davalos; Olivier Naggara; Michael D Hill; Serge Bracard
Journal:  JAMA Neurol       Date:  2019-04-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.